Dendritic cell/multiple myeloma fusion vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dendritic cell/multiple myeloma fusion vaccine, covering 2025-09-02 to 2025-09-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma [Phase 1]